nach oben

Erschienen in:

12.07.2018 | Original Article

Injectable platelet rich fibrin: cell content, morphological, and protein characterization

verfasst von: Hugo Almeida Varela, Júlio C. M. Souza, Rubens M. Nascimento, Raimundo F. Araújo Jr, Roseane C. Vasconcelos, Rômulo S. Cavalcante, Paulo M. Guedes, Aurigena A. Araújo

Erschienen in: Clinical Oral Investigations | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of the present study was to evaluate the blood cell content, morphological aspects, gene expression of type I collagen, and release of growth factors on an injectable platelet rich fibrin (i-PRF).

Materials and methods

Blood samples were collected from 15 volunteers to prepare i-PRF samples. Peripheral blood was used as a control group. Blood clot and i-PRF samples were cultured for 10 days. The supernatant of the samples was collected for ELISA immunoassay quantification of PDGF and VEGF growth factors over periods of 1, 8, 24, 72, and 240 h. I-PRF and blood clot samples were biologically characterized using histological and immunohistochemistry analysis for IL-10, osteocalcin, and TGF-β. Scanning electron microscopy (SEM) was used to inspect the fibrin network and distribution of blood platelets and leukocytes. Reverse transcriptase polymerase chain reaction (RT-PCR) method was used to evaluate gene expression for type I collagen.

Results

A higher concentration of platelets and lymphocytes was recorded in i-PRF than in peripheral blood (p < 0.05). The release of VEGF was higher in blood clot samples (1933 ± 704) than that for i-PRF (852 ± 376; p < 0.001). Immunohistochemistry showed upregulation of TGF-B, IL-10, and osteocalcin in the i-PRF group. RT-PCR showed increased type I collagen gene expression in i-PRF (p < 0.05). SEM images revealed agglomeration of platelets in some regions, while a fibrin networking was noticeable in the entire i-PRF sample.

Conclusions

Injectable platelet rich fibrin becomes a good approach for soft and mineralized tissue healing considering the formation of a three-dimensional fibrin network embedding platelets, leukocytes, type I collagen, osteocalcin, and growth factors. Indeed, the injectable platelet rich fibrin can be indicated in several medical applications regarding bioactivity, simplied technique, and flowable mixing with other biomaterials.

Clinical relevance

Morphological, cell, and protein characterization of platelet rich fibrin provides a better understanding of the clinical effects and improvement of clinical guidelines for several medical applications. Once well physicochemical and biologically characterized, the use of an injectable platelet rich fibrin can be extended to other applications in the field of orthopedics, periodontics, and implant dentistry on the repairing process of both soft and mineralized tissues.

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e37–e44. https://doi.org/10.1016/j.tripleo.2005.07.008 CrossRefPubMed

Marcazzan S, Weinstein RL, Del Fabbro M (2017) Efficacy of platelets in bone healing: a systematic review on animal studies. Platelets 29:1–12. https://doi.org/10.1080/09537104.2017.1327652 CrossRef

Abraham CM (2014) A brief historical perspective on dental implants, their surface coatings and treatments. Open Dent J 8(1):50–55. https://doi.org/10.2174/1874210601408010050 CrossRefPubMedPubMedCentral

Sood V, Masamatti SS, Khatri M, Kumar A, Jindal V (2012) Platelet concentrates–part I. Indian J Dent Sci 4(4):123–126

Wu C-L, Lee S-S, Tsai C-H, Lu K-H, Zhao J-H, Chang Y-C (2012) Platelet-rich fibrin increases cell attachment, proliferation and collagen-related protein expression of human osteoblasts. Aust Dent J 57(2):207–212. https://doi.org/10.1111/j.1834-7819.2012.01686.x CrossRefPubMed

Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, Quirynen M (2017) Regenerative potential of leucocyte- and platelet-rich fibrin. Part A: intra-bony defects, furcation defects and periodontal plastic surgery. A systematic review and meta-analysis. J Clin Periodontol 44(1):67–82. https://doi.org/10.1111/jcpe.12643 CrossRefPubMed

Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, Quirynen M (2017) Regenerative potential of leucocyte- and platelet-rich fibrin. Part B: sinus floor elevation, alveolar ridge preservation and implant therapy. A systematic review. J Clin Periodontol 44(2):225–234. https://doi.org/10.1111/jcpe.12658 CrossRefPubMedPubMedCentral

Del Corso M, Dohan Ehrenfest DM (2013) Immediate implantation and peri-implant natural bone regeneration (NBR) in the severely resorbed posterior mandible using leukocyte-and platelet-rich fibrin (L-PRF): a 4-year follow-up. http://asnanportal.com/images/dental_report/periodontics-oral-surgery-implants/poseido-201312109-16-delcor-copia.pdf

Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM (2009) The relevance of Choukrounʼs platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: implant surgery, prosthodontics, and survival. Implant Dent 18(3):220–229. https://doi.org/10.1097/ID.0b013e31819b5e3f CrossRefPubMed

10.

Mosesson MW, Siebenlist KR, Meh DA (2006) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936(1):11–30. https://doi.org/10.1111/j.1749-6632.2001.tb03491.x CrossRef

11.

Guthold M, Liu W, Sparks EA, Jawerth LM, Peng L, Falvo M, Superfine R, Hantgan RR, Lord ST (2007) A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers. Cell Biochem Biophys 49(3):165–181. https://doi.org/10.1007/s12013-007-9001-4 CrossRefPubMedPubMedCentral

12.

Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ (2017) Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets 29:1–8. https://doi.org/10.1080/09537104.2017.1293807. CrossRef

13.

Mourão CF de AB, Valiense H, Melo ER, Mourão NBMF, Maia MD-C (2015) Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft. Rev Col Bras Cir 42(6):421–423CrossRef

14.

Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ (2017) Behavior of gingival fibroblasts on titanium implant surfaces in combination with either injectable-PRF or PRP. Int J Mol Sci 18(2):E331. https://doi.org/10.3390/ijms18020331 CrossRefPubMed

15.

Choukroun J, Ghanaati S (2017) Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients??? Own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Eur J Trauma Emerg Surg 44:1–9

16.

Miron RJ, Fujioka-Kobayashi M, Hernandez M et al (2017) Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig 21:1–9CrossRef

17.

Chomczynski P, Sacchi N (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate – phenol – chloroform extraction: twenty-something years on. Nat Protoc 1(2):581–585. https://doi.org/10.1038/nprot.2006.83 CrossRefPubMed

18.

Ota-Tsuzuki C, Datte CE, Nomura KA, Gouvea Cardoso LA, Shibli JA (2011) Influence of titanium surface treatments on formation of the blood clot extension. J Oral Implantol 37(6):641–647. https://doi.org/10.1563/AAID-JOI-D-09-00125.1 CrossRefPubMed

19.

Fujioka-Kobayashi M, Miron RJ, Hernandez M, Kandalam U, Zhang Y, Choukroun J (2016) Optimized platelet rich fibrin with the low speed concept: growth factor release, biocompatibility and cellular response. J Periodontol 88:1–17. https://doi.org/10.1902/jop.2016.160443 CrossRef

20.

Weibrich G, Kleis WKG, Hafner G, Hitzler WE (2002) Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30(2):97–102. https://doi.org/10.1054/jcms.2002.0285 CrossRefPubMed

21.

El-Sharkawy H, Kantarci A, Deady J et al (2007) Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 78(4):661–669. https://doi.org/10.1902/jop.2007.060302 CrossRefPubMed

22.

Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier J-B (2010) Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol 81(4):546–555. https://doi.org/10.1902/jop.2009.090531 CrossRefPubMed

23.

Nishimoto S, Fujita K, Sotsuka Y, Kinoshita M, Fujiwara T, Kawai K, Kakibuchi M (2015) Growth factor measurement and histological analysis in platelet rich fibrin: a pilot study. J Maxillofac Oral Surg 14(4):907–913. https://doi.org/10.1007/s12663-015-0768-3 CrossRefPubMedPubMedCentral

24.

Schär MO, Diaz-Romero J, Kohl S, Zumstein MA, Nesic D (2015) Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro. Clin Orthop Relat Res 473(5):1635–1643. https://doi.org/10.1007/s11999-015-4192-2 CrossRefPubMedPubMedCentral

25.

Andrade CX, Orrego A, Pinto N (2016) Hematologic profile of four autologous fibrinogen based binder obtained with differents protocols. In :2–3. doi:https://doi.org/10.13140/RG.2.2.27106.12485

26.

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e51–e55. https://doi.org/10.1016/j.tripleo.2005.07.010. CrossRefPubMed

27.

Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB (2010) Choukroun’s platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol 55(3):185–194. https://doi.org/10.1016/j.archoralbio.2010.01.004 CrossRefPubMed

28.

Bielecki T, Dohan Ehrenfest DM, Everts PA, Wiczkowski A (2012) The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: new perspectives. Curr Pharm Biotechnol 13(7):1153–1162. https://doi.org/10.2174/138920112800624373. CrossRefPubMed

29.

Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G (2009) Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 27(1):63–69. https://doi.org/10.1080/08977190802636713. CrossRefPubMed

30.

Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJJ, Mouhyi J, Dohan DM (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):299–303. https://doi.org/10.1016/j.tripleo.2005.07.012 CrossRefPubMed

31.

Yajamanya SR, Chatterjee A, Babu CN, Karunanithi D (2016) Fibrin network pattern changes of platelet-rich fibrin in young versus old age group of individuals: a cell block cytology study. J Indian Soc Periodontol 20(2):151–156PubMedPubMedCentral

32.

Dohan Ehrenfest DM, Pinto NR, Pereda A et al (2017) The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane. Platelets 29:1–14

33.

Clark RAF (2006) Fibrin and wound healing. Ann N Y Acad Sci 936(1):355–367. https://doi.org/10.1111/j.1749-6632.2001.tb03522.x CrossRef

34.

Xie X, Zhang C, Tuan RS (2014) Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther 16(1):204. https://doi.org/10.1186/ar4493 CrossRefPubMedPubMedCentral

35.

Kawase T, Okuda K, Wolff LF, Yoshie H (2003) Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol 74(6):858–864. https://doi.org/10.1902/jop.2003.74.6.858 CrossRefPubMed

36.

Janmey PA, Winer JP, Weisel JW (2009) Fibrin gels and their clinical and bioengineering applications. J R Soc Interface 6(30):1–10. https://doi.org/10.1098/rsif.2008.0327 CrossRefPubMed

37.

Kobayashi M, Kawase T, Horimizu M, Okuda K, Wolff LF, Yoshie H (2012) A proposed protocol for the standardized preparation of PRF membranes for clinical use. Biologicals 40(5):323–329. https://doi.org/10.1016/j.biologicals.2012.07.004 CrossRefPubMed

38.

Kang Y-H, Jeon SH, Park J-Y, Chung JH, Choung YH, Choung HW, Kim ES, Choung PH (2011) Platelet-rich fibrin is a bioscaffold and reservoir of growth factors for tissue regeneration. Tissue Eng A 17(3–4):349–359. https://doi.org/10.1089/ten.tea.2010.0327 CrossRef

39.

Cieslik-Bielecka A, Bielecki T, Gazdzik TS, Arendt J, Król W, Szczepanski T (2009) Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus Apher Sci 41(1):9–12. https://doi.org/10.1016/j.transci.2009.05.006 CrossRefPubMed

40.

Shi S, Kirk M, Kahn AJ (2009) The role of type I collagen in the regulation of the osteoblast phenotype. J Bone Miner Res 11(8):1139–1145. https://doi.org/10.1002/jbmr.5650110813 CrossRef

41.

Franceschi RT (1999) The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med 10(1):40–57. https://doi.org/10.1177/10454411990100010201 CrossRefPubMed

Titel: Injectable platelet rich fibrin: cell content, morphological, and protein characterization
verfasst von: Hugo Almeida Varela
Júlio C. M. Souza
Rubens M. Nascimento
Raimundo F. Araújo Jr
Roseane C. Vasconcelos
Rômulo S. Cavalcante
Paulo M. Guedes
Aurigena A. Araújo
Publikationsdatum: 12.07.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 3/2019
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-018-2555-2

Neu im Fachgebiet Zahnmedizin

19.04.2024 | Vorhofflimmern | Nachrichten

Newsletter bestellen

Springer Medizin

Injectable platelet rich fibrin: cell content, morphological, and protein characterization

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter

Springer Medizin

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Zn-containing polymer nanogels promote cervical dentin remineralization

In vitro visual and visible light transillumination methods for detection of natural non-cavitated approximal caries

Salivary levels and immunohistochemical expression of selected angiogenic factors in benign and malignant parotid gland tumours

Candidate gene sequencing reveals mutations causing hypoplastic amelogenesis imperfecta

Variable impact by ambient temperature on fatigue resistance of heat-treated nickel titanium instruments

Analysis of blood supply in the hard palate and maxillary tuberosity—clinical implications for flap design and soft tissue graft harvesting (a human cadaver study)

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter